不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南

被引:1773
作者
柯元南
陈纪林
机构
[1] 中华医学会心血管病学分会
[2] 中华心血管病杂志编辑委员会
关键词
心肌梗死; 患者; UA; NSTEMI; 心绞痛; 冠心病; 证据水平; 心肌损伤标记物; 阿司匹林; 乙酰水杨酸; 受体阻滞剂; 冠状动脉造影检查; ACS; PCI; ST; 治疗指南; 心肌缺血; 血管重建; CABG; 肌钙蛋白; 肌肉蛋白;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
<正> 近年来,对不稳定性心绞痛(unstable angina,UA)和非ST 段抬高心肌梗死(non-ST-elevation myocardial infarction,NSTEMI)病理生理机制的认识逐步深入,有关大规模临床试验结果陆续问世,其临床治疗也有重要进展。为了更好的总结这些经验,合理指导临床实践,中华医学会心血管病学分会、中华心血管病杂志编辑委员会根据近年来有关临床试验的研究结果,参考美国心脏病学会(ACC)/美国心脏协会(AHA)及欧洲心脏病学会(ESC)的有关指南,并结合我国心血管病防治的具体情况,组织有关专家制定了我国 UA
引用
收藏
页码:295 / 304
页数:10
相关论文
共 7 条
[1]  
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines[J] . Scott M. Grundy,James I. Cleeman,C. Noel Bairey Merz,H. Bryan Brewer,Luther T. Clark,Donald B. Hunninghake,Richard C. Pasternak,Sidney C. Smith,Neil J. Stone.Journal of the American College of Cardiology . 2004 (3)
[2]  
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial[J] . The Lancet . 2001 (9272)
[3]  
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non-Q-Wave Myocardial Infarction: Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B Trial[J] . Elliott M. Antman,Carolyn H. McCabe,Enrique P. Gurfinkel,Alexander G.G. Turpie,Peter J.L.M. Bernink,Diana Salein,Antonio Bayes de Luna,Kim Fox,Jean-Marc Lablanche,David Radley,Jerome Premmereur,Eugene Braunwald.Circulation . 1999 (15)
[4]  
ISIS-2: 10 Year Survival among Patients with Suspected Acute Myocardial Infarction in Randomised Comparison of Intravenous Streptokinase, Oral Aspirin, Both, or Neither[J] . Colin Baigent,Rory Collins,Paul Appleby,Sarah Parish,Peter Sleight,Richard Peto.BMJ: British Medical Journal . 1998 (7141)
[5]  
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study[J] . The Lancet . 1997 (9063)
[6]   Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction [J].
Fuster, V ;
Califf, RM ;
Chesebro, JH ;
Cohen, M ;
Comp, PC ;
Gheorghiade, M ;
Hall, J ;
Halperin, J ;
Khan, S ;
Kopecky, S ;
Langer, A ;
Molk, B ;
Moss, A ;
OConnor, CM ;
OGara, PT ;
Raskob, E ;
Sutton, J ;
Braunwald, E ;
Bell, WR ;
Furberg, C ;
Rapaport, E ;
DeMets, D ;
Goldstein, S ;
Richardson, D ;
Hillis, D ;
Bonow, R ;
Kistler, JP ;
Mohr, JP ;
Sherman, D ;
Fisher, M ;
Feyzi, J ;
Cook, T ;
Califf, RM ;
Harrington, RA ;
Berkowitz, SD ;
Jett, L ;
Berdan, L ;
McDougal, M ;
Friedman, E ;
Daniel, J ;
Roncskevitz, E ;
Hwang, S ;
Crowell, D ;
Paganini, M ;
Andahl, L ;
OConnor, C ;
Lucas, K ;
Collins, GJ ;
Mark, RJ ;
Siegel, RM .
LANCET, 1997, 350 (9075) :389-396
[7]  
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)[J] . The Lancet . 1996 (9038)